Fig. 11
From: Unraveling the role of HIF2α in melanoma progression and epithelial–mesenchymal transition
Differential expression of HIF2α in relation to clinical features and staging. (A) Differential expression of HIF2α across different age groups. (B) Differential expression of HIF2α in relation to survival status. (C) Differential expression of HIF2α across different genders. (D) Differential expression of HIF2α in male patients across T stages. (E) Differential expression of HIF2α in male patients across M stages. (F) Differential expression of HIF2α in male patients across clinical stages. (G) Survival analysis of patients with high vs. low HIF2α expression.
